139 related articles for article (PubMed ID: 24850721)
1. Macrophages engulfing apoptotic cells produce nonclassical retinoids to enhance their phagocytic capacity.
Sarang Z; Joós G; Garabuczi É; Rühl R; Gregory CD; Szondy Z
J Immunol; 2014 Jun; 192(12):5730-8. PubMed ID: 24850721
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids enhance prolonged clearance of apoptotic cells by upregulating liver X receptor, peroxisome proliferator-activated receptor-δ and UCP2.
Garabuczi É; Sarang Z; Szondy Z
Biochim Biophys Acta; 2015 Mar; 1853(3):573-82. PubMed ID: 25523142
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells.
Tóth B; Garabuczi E; Sarang Z; Vereb G; Vámosi G; Aeschlimann D; Blaskó B; Bécsi B; Erdõdi F; Lacy-Hulbert A; Zhang A; Falasca L; Birge RB; Balajthy Z; Melino G; Fésüs L; Szondy Z
J Immunol; 2009 Feb; 182(4):2084-92. PubMed ID: 19201861
[TBL] [Abstract][Full Text] [Related]
4. Retinoids produced by macrophages engulfing apoptotic cells contribute to the appearance of transglutaminase 2 in apoptotic thymocytes.
Garabuczi É; Kiss B; Felszeghy S; Tsay GJ; Fésüs L; Szondy Z
Amino Acids; 2013 Jan; 44(1):235-44. PubMed ID: 21997537
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
Falasca L; Iadevaia V; Ciccosanti F; Melino G; Serafino A; Piacentini M
J Immunol; 2005 Jun; 174(11):7330-40. PubMed ID: 15905580
[TBL] [Abstract][Full Text] [Related]
6. Adenosine produced from adenine nucleotides through an interaction between apoptotic cells and engulfing macrophages contributes to the appearance of transglutaminase 2 in dying thymocytes.
Sándor K; Pallai A; Duró E; Legendre P; Couillin I; Sághy T; Szondy Z
Amino Acids; 2017 Mar; 49(3):671-681. PubMed ID: 27236567
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of integrin beta3 can partially overcome the defect of integrin beta3 signaling in transglutaminase 2 null macrophages.
Tóth B; Sarang Z; Vereb G; Zhang A; Tanaka S; Melino G; Fésüs L; Szondy Z
Immunol Lett; 2009 Sep; 126(1-2):22-8. PubMed ID: 19643138
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1.
Fond AM; Lee CS; Schulman IG; Kiss RS; Ravichandran KS
J Clin Invest; 2015 Jul; 125(7):2748-58. PubMed ID: 26075824
[TBL] [Abstract][Full Text] [Related]
10. Macrophages engulfing apoptotic thymocytes produce retinoids to promote selection, differentiation, removal and replacement of double positive thymocytes.
Sarang Z; Garabuczi É; Joós G; Kiss B; Tóth K; Rühl R; Szondy Z
Immunobiology; 2013 Nov; 218(11):1354-60. PubMed ID: 23932496
[TBL] [Abstract][Full Text] [Related]
11. No constitutive defect in phagocytosis of apoptotic cells by resident peritoneal macrophages from pre-morbid lupus mice.
Licht R; Jacobs CW; Tax WJ; Berden JH
Lupus; 2001; 10(2):102-7. PubMed ID: 11237121
[TBL] [Abstract][Full Text] [Related]
12. Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages.
Rébé C; Raveneau M; Chevriaux A; Lakomy D; Sberna AL; Costa A; Bessède G; Athias A; Steinmetz E; Lobaccaro JM; Alves G; Menicacci A; Vachenc S; Solary E; Gambert P; Masson D
Circ Res; 2009 Aug; 105(4):393-401. PubMed ID: 19628791
[TBL] [Abstract][Full Text] [Related]
13. Decreased phagocytosis of apoptotic cells in diseased SLE mice.
Licht R; Dieker JW; Jacobs CW; Tax WJ; Berden JH
J Autoimmun; 2004 Mar; 22(2):139-45. PubMed ID: 14987742
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
[TBL] [Abstract][Full Text] [Related]
15. ATP-binding cassette transporter 1 and transglutaminase 2 act on the same genetic pathway in the apoptotic cell clearance.
Iadevaia V; Rinaldi A; Falasca L; Pucillo LP; Alonzi T; Chimini G; Piacentini M
Cell Death Differ; 2006 Nov; 13(11):1998-2001. PubMed ID: 16691213
[No Abstract] [Full Text] [Related]
16. Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients.
Majai G; Kiss E; Tarr T; Zahuczky G; Hartman Z; Szegedi G; Fésüs L
Lupus; 2014 Feb; 23(2):133-45. PubMed ID: 24285095
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.
A-Gonzalez N; Bensinger SJ; Hong C; Beceiro S; Bradley MN; Zelcer N; Deniz J; Ramirez C; Díaz M; Gallardo G; de Galarreta CR; Salazar J; Lopez F; Edwards P; Parks J; Andujar M; Tontonoz P; Castrillo A
Immunity; 2009 Aug; 31(2):245-58. PubMed ID: 19646905
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis and clearance of apoptotic cells is mediated by MER.
Scott RS; McMahon EJ; Pop SM; Reap EA; Caricchio R; Cohen PL; Earp HS; Matsushima GK
Nature; 2001 May; 411(6834):207-11. PubMed ID: 11346799
[TBL] [Abstract][Full Text] [Related]
19. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling.
Sarang Z; Köröskényi K; Pallai A; Duró E; Melino G; Griffin M; Fésüs L; Szondy Z
Immunol Lett; 2011 Jul; 138(1):71-8. PubMed ID: 21420434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]